MedTrace Logo

Post-Approval Study With the KAMRA Inlay

NCT03173664 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 529

Last updated 2018-05-18

No results posted yet for this study

Summary

KAMRA inlay, to be unilaterally implanted into the cornea of a subject's non-dominant eye. The inlay is to be inserted into a stromal pocket created with a surgical femtosecond laser.

Conditions

Interventions

DEVICE

KAMRA Inlay

Unilateral implantation of the KAMRA inlay in the corneal stroma.

Sponsors & Collaborators

  • AcuFocus, Inc.

    lead INDUSTRY

Principal Investigators

  • TBD TBD, M.D.

Eligibility

Min Age
45 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-31
Primary Completion
2026-01-31
Completion
2026-01-31
FDA Device
Yes

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03173664 on ClinicalTrials.gov